Clinical Trials Directory

Trials / Unknown

UnknownNCT04705064

Artificial Intelligence and Postoperative Acute Kidney Injury

Development and Prospective Validation of an Artificial Intelligence Model to Predict Postoperative Acute Kidney Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The main objective of this study is to develop and validate an artificial intelligence model that predicts postoperative acute kidney injury.

Detailed description

Postoperative acute kidney injury is known to increase the length of hospital stay and healthcare cost. A lot of risk prediction models have been developed for identifying patients at increased risk of postoperative acute kidney injury. Recent advances in artificial intelligence make it possible to manage and analyze big data. Prediction model using an artificial intelligence and large-scale data can improve the accuracy of prediction performance. Furthermore, the use of an artificial intelligence may be a useful adjuvant tool in making clinical decisions or real-time prediction if it is integrated into the electrical medical record systems. However, before implementing an artificial intelligence model into the clinical setting, prospective evaluation of an artificial intelligence model's real performance is essential. However, to our knowledge, there was no artificial intelligence model for prediction of postoperative acute kidney injury, which was prospectively evaluated. Therefore, we aimed to develop an artificial intelligence model which predicts postoperative acute kidney injury and evaluate the model's performance prospectively.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPrediction of postoperative acute kidney injury using an artificial intelligenceThe performance of an artificial intelligence model to predict postoperative acute kidney injury will be tested prospectively.

Timeline

Start date
2021-03-01
Primary completion
2021-05-31
Completion
2022-02-01
First posted
2021-01-12
Last updated
2021-01-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04705064. Inclusion in this directory is not an endorsement.